Skip to main content

Gossamer Bio Inc

For the period ended Jun 30, 2024. Filed Aug 12, 2024.

View on SEC.gov

About this filing

A company's report for each of its first three quarters. The financial statements are not audited. It shows how the business has moved since the last annual report, and what management says changed.

Jun 30, 2024 · Filed Aug 12, 2024

GOSS$10.65+9.0%Stored close · as of Nov 9, 2026

Extracted filing text, with the paragraph anchors used by the comparison.

See the whole filing, with its images and exhibits

Table of Contents

PART I. FINANCIAL INFORMATION
Item 1Condensed Consolidated Financial Statements (unaudited)4
Condensed Consolidated Balance Sheets as of June 30, 2024 (unaudited) and December 31, 20234
Condensed Consolidated Statements of Operations and Comprehensive Income (Loss) for the Three and Six Months ended June 30, 2024 and 2023 (unaudited)5
Condensed Consolidated Statements of Stockholders’ Equity (Deficit) for the Three and Six Months ended June 30, 2024 and 2023 (unaudited)6
Condensed Consolidated Statements of Cash Flows for the Six Months ended June 30, 2024 and 2023 (unaudited)7
Notes to Unaudited Condensed Consolidated Financial Statements8
Item 2Management’s Discussion and Analysis of Financial Condition and Results of Operations26
Item 3Quantitative and Qualitative Disclosures About Market Risk35
Item 4Controls and Procedures35
PART II. OTHER INFORMATION
Item 1Legal Proceedings36
Item 1ARisk Factors36
Item 2Unregistered Sales of Equity Securities and Use of Proceeds36
Item 3Defaults Upon Senior Securities36
Item 4Mine Safety Disclosures36
Item 5Other Information36
Item 6Exhibits36
Exhibit Index37
Signatures38
ContentsView on SEC.gov

The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.